NCT05299229View on ClinicalTrials.gov

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Pre-Eclampsia
Interventions
DIAGNOSTIC_TEST

Echocardiogrpahy and non-invasive monitoring

Study participants will have echocardiography and non-invasive monitoring by chest/back sensors and a finger cuff.

Trial Locations (1)

06510

Yale University Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT05299229 - Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements | Biotech Hunter | Biotech Hunter